skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France
Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France
Material Type:
Artigo 		Adicionar ao Meu Espaço

Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France

Corvest, Victoria ; Marec‐Bérard, Perrine ; Lervat, Cyril ; Pacquement, Hélène ; Toulmonde, Maud ; Gentet, Jean‐Claude ; Laurence, Valérie ; Cleirec, Morgane ; Mansuy, Ludovic ; Bompas, Emmanuelle ; Castex, Marie‐Pierre ; Taque, Sophie ; Filhon, Bruno ; Tabone, Marie‐Dominique ; Verité, Cécile ; Entz‐Werle, Natacha ; Saumet, Laure ; Guimard, Gregory ; Pondrom, Morgane ; Chevreau, Christine ; Flandrin, Jennifer ; Duranteau, Lise ; Rousset‐Jablonski, Christine ; Brugières, Laurence ; Jimenez, Marta ; Le Deley, Marie‐Cécile ; Gaspar, Nathalie ; Fresneau, Brice

International journal of cancer, 2023-04, Vol.152 (8), p.1659-1667 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
2
Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study
Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Arterial Stiffness Use for Early Monitoring of Cardiovascular Adverse Events due to Anthracycline Chemotherapy in Breast Cancer Patients. A Pilot Study

Souza, Cláudio Antônio de ; Simões, Ricardo ; Borges, Karina Braga Gomes ; Oliveira, Angélica Navarro de ; Zogeib, Juliana Barroso ; Alves, Bruno ; Malachias, Marcus Vinicius Bolívar ; Drummond-Lage, Ana Paula ; Rezende, Bruno Almeida

Arquivos brasileiros de cardiologia, 2018-11, Vol.111 (5), p.721-728 [Periódico revisado por pares]

Brazil: Sociedade Brasileira de Cardiologia - SBC

Texto completo disponível

Citações Citado por
3
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, Hervé ; Morschhauser, Franck ; Sehn, Laurie H ; Friedberg, Jonathan W ; Trněný, Marek ; Sharman, Jeff P ; Herbaux, Charles ; Burke, John M ; Matasar, Matthew ; Rai, Shinya ; Izutsu, Koji ; Mehta-Shah, Neha ; Oberic, Lucie ; Chauchet, Adrien ; Jurczak, Wojciech ; Song, Yuqin ; Greil, Richard ; Mykhalska, Larysa ; Bergua-Burgués, Juan M ; Cheung, Matthew C ; Pinto, Antonio ; Shin, Ho-Jin ; Hapgood, Greg ; Munhoz, Eduardo ; Abrisqueta, Pau ; Gau, Jyh-Pyng ; Hirata, Jamie ; Jiang, Yanwen ; Yan, Mark ; Lee, Calvin ; Flowers, Christopher R ; Salles, Gilles

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
4
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Locke, Frederick L ; Ghobadi, Armin ; Jacobson, Caron A ; Miklos, David B ; Lekakis, Lazaros J ; Oluwole, Olalekan O ; Lin, Yi ; Braunschweig, Ira ; Hill, Brian T ; Timmerman, John M ; Deol, Abhinav ; Reagan, Patrick M ; Stiff, Patrick ; Flinn, Ian W ; Farooq, Umar ; Goy, Andre ; McSweeney, Peter A ; Munoz, Javier ; Siddiqi, Tanya ; Chavez, Julio C ; Herrera, Alex F ; Bartlett, Nancy L ; Wiezorek, Jeffrey S ; Navale, Lynn ; Xue, Allen ; Jiang, Yizhou ; Bot, Adrian ; Rossi, John M ; Kim, Jenny J ; Go, William Y ; Neelapu, Sattva S

The lancet oncology, 2019-01, Vol.20 (1), p.31-42 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes, Anas ; Sehn, Laurie H ; Johnson, Peter ; Zinzani, Pier Luigi ; Hong, Xiaonan ; Zhu, Jun ; Patti, Caterina ; Belada, David ; Samoilova, Olga ; Suh, Cheolwon ; Leppä, Sirpa ; Rai, Shinya ; Turgut, Mehmet ; Jurczak, Wojciech ; Cheung, Matthew C ; Gurion, Ronit ; Yeh, Su-Peng ; Lopez-Hernandez, Andres ; Dührsen, Ulrich ; Thieblemont, Catherine ; Chiattone, Carlos Sergio ; Balasubramanian, Sriram ; Carey, Jodi ; Liu, Grace ; Shreeve, S Martin ; Sun, Steven ; Zhuang, Sen Hong ; Vermeulen, Jessica ; Staudt, Louis M ; Wilson, Wyndham

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1285-1295 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H ; Saji, Shigehira ; Jung, Kyung Hae ; Hegg, Roberto ; Koehler, Andreas ; Sohn, Joohyuk ; Iwata, Hiroji ; Telli, Melinda L ; Ferrario, Cristiano ; Punie, Kevin ; Penault-Llorca, Frédérique ; Patel, Shilpen ; Duc, Anh Nguyen ; Liste-Hermoso, Mario ; Maiya, Vidya ; Molinero, Luciana ; Chui, Stephen Y ; Harbeck, Nadia

The Lancet (British edition), 2020-10, Vol.396 (10257), p.1090-1100 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Shanafelt, Tait D ; Wang, Xin V ; Kay, Neil E ; Hanson, Curtis A ; O’Brien, Susan ; Barrientos, Jacqueline ; Jelinek, Diane F ; Braggio, Esteban ; Leis, Jose F ; Zhang, Cong C ; Coutre, Steven E ; Barr, Paul M ; Cashen, Amanda F ; Mato, Anthony R ; Singh, Avina K ; Mullane, Michael P ; Little, Richard F ; Erba, Harry ; Stone, Richard M ; Litzow, Mark ; Tallman, Martin

The New England journal of medicine, 2019-08, Vol.381 (5), p.432-443 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

Loibl, S. ; Untch, M. ; Burchardi, N. ; Huober, J. ; Sinn, B.V. ; Blohmer, J.-U. ; Grischke, E.-M. ; Furlanetto, J. ; Tesch, H. ; Hanusch, C. ; Engels, K. ; Rezai, M. ; Jackisch, C. ; Schmitt, W.D. ; von Minckwitz, G. ; Thomalla, J. ; Kümmel, S. ; Rautenberg, B. ; Fasching, P.A. ; Weber, K. ; Rhiem, K. ; Denkert, C. ; Schneeweiss, A.

Annals of oncology, 2019-08, Vol.30 (8), p.1279-1288 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Ovarian damage from chemotherapy and current approaches to its protection
Ovarian damage from chemotherapy and current approaches to its protection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ovarian damage from chemotherapy and current approaches to its protection

Spears, N ; Lopes, F ; Stefansdottir, A ; Rossi, V ; De Felici, M ; Anderson, R A ; Klinger, F G

Human reproduction update, 2019-11, Vol.25 (6), p.673-693 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
10
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Nowakowski, Grzegorz S ; Chiappella, Annalisa ; Gascoyne, Randy D ; Scott, David W ; Zhang, Qingyuan ; Jurczak, Wojciech ; Özcan, Muhit ; Hong, Xiaonan ; Zhu, Jun ; Jin, Jie ; Belada, David ; Bergua, Juan Miguel ; Piazza, Francesco ; Mócikova, Heidi ; Molinari, Anna Lia ; Yoon, Dok Hyun ; Cavallo, Federica ; Tani, Monica ; Yamamoto, Kazuhito ; Izutsu, Koji ; Kato, Koji ; Czuczman, Myron ; Hersey, Sarah ; Kilcoyne, Adrian ; Russo, Jacqueline ; Hudak, Krista ; Zhang, Jingshan ; Wade, Steve ; Witzig, Thomas E ; Vitolo, Umberto

Journal of clinical oncology, 2021-04, Vol.39 (12), p.1317-1328 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (8.437)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (9.045)
  2. magazinearticle  (8)
  3. Web Resources  (1)
  4. Archival Material / Manuscripts  (1)
  5. Reports  (1)
  6. Anais de Congresso  (1)
  7. Book Chapters  (1)
  8. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1976  (390)
  2. 1976Até1987  (959)
  3. 1988Até1999  (1.595)
  4. 2000Até2012  (3.242)
  5. Após 2012  (2.882)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (8.770)
  2. Japonês  (965)
  3. Alemão  (109)
  4. Francês  (62)
  5. Espanhol  (37)
  6. Russo  (25)
  7. Português  (23)
  8. Chinês  (16)
  9. Italiano  (9)
  10. Holandês  (5)
  11. Polonês  (4)
  12. Norueguês  (3)
  13. Croatian  (3)
  14. Húngaro  (2)
  15. Tcheco  (2)
  16. Turco  (2)
  17. Sueco  (2)
  18. Serbian  (1)
  19. Hebraico  (1)
  20. Dinamarquês  (1)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.